ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2022

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 61 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$2,937,0416.08%
BML Capital Management, LLC 7,067,179$4,095,4303.91%
Sonic GP LLC 4,552,068$2,637,9231.98%
AIGH Capital Management LLC 1,200,000$695,4000.23%
Newtyn Management, LLC 1,635,000$947,4820.20%
Monaco Asset Management SAM 659,575$382,2240.12%
Worth Venture Partners, LLC 298,560$173,0160.10%
CM Management, LLC 100,000$580.07%
GSA CAPITAL PARTNERS LLP 830,829$4810.06%
Oasis Management Co Ltd. 465,000$269,4680.05%
Quinn Opportunity Partners LLC 398,298$230,8140.03%
Marquette Asset Management, LLC 121,393$70,3470.02%
Lipe & Dalton 15,000$90.01%
OCCUDO QUANTITATIVE STRATEGIES LP 78,339$45,3970.01%
CANTOR FITZGERALD, L. P. 135,000$780.00%
Ergoteles LLC 82,499$47,8080.00%
Assenagon Asset Management S.A. 840,651$4870.00%
Tower Research Capital LLC (TRC) 25,144$150.00%
Virtu Financial LLC 17,174$100.00%
Renaissance Technologies 1,074,241$6230.00%
External links

This page lists ADVERUM BIOTECHNOLOGIES INC's shareholders in Q4 2022. To view ADVERUM BIOTECHNOLOGIES INC's shareholder history, click here.